Vaccine Track Resources

Adult Vaccines - FY 2023 Update
Mon, Jun 10, 2024

Data from Vaccine Track for the full year of 2023 continue to show a broad upward trend in adult vaccinations compared to the years immediately following the pandemic, suggesting that soon, the number of vaccination claims could consistently equal pre-pandemic levels. In 2023, overall adult vaccination claims were 7% lower than the claims in 2019, whereas vaccination claims in 2022 were nearly 15% lower than in 2019. Of note, for the first three quarters of 2023, vaccination claims exceeded 2019 levels by 1%.

Read more
Adult Vaccines - H1 2023 Update
Thu, Dec 7, 2023

Vaccinations continued to increase from January through June of 2023 as compared to the same time last year. In comparison to pre-pandemic levels, this marks the first time there has been an increase in H1 national immunization claims.

Read more
National Immunization Awareness Month Update
Thu, Aug 24, 2023

August is National Immunization Awareness Month (NIAM), which emphasizes the importance of routine immunization for people of all ages. This year, NIAM also highlights additional trends to watch for, including the implications of the end of the COVID-19 public health emergency, the expansion of full vaccine coverage without cost sharing for Medicare and Medicaid beneficiaries, and the FDA approval of new vaccines.

Read more
Optimizing Adult Immunizations in the U.S.
Thu, Jun 1, 2023

This white paper from CapView Strategies outlines the current vaccine coverage landscape in the US and offers tangible solutions for addressing adult immunization gaps. The paper reviews coverage of recommended vaccines in the U.S. since the passage of the Inflation Reduction Act, including expansions in vaccine coverage for adults in Medicare and Medicaid.

Read more
Adult Vaccines - Outlook for 2023
Thu, Feb 9, 2023

The COVID-19 pandemic had a significant impact on decreasing routine immunization rates both for children and adults — but it also provided lessons learned on how to address equity issues and system barriers that can be leveraged moving forward to improve rates. This is especially important to protect against respiratory diseases as we saw this year with the “tripledemic.”

Read more